Controlled conversion of an immortalized mesodermal progenitor cell towards osteogenic, chondrogenic, or adipogenic pathways.
about
Scleraxis messenger ribonucleic acid is expressed in C2C12 myoblasts and its level is down-regulated by bone morphogenetic protein-2 (BMP2)Advances in the osteoblast lineage.Serotonergic 5-HT(2B) receptor controls tissue-nonspecific alkaline phosphatase activity in osteoblasts via eicosanoids and phosphatidylinositol-specific phospholipase CIncreased adipogenesis in cultured embryonic chondrocytes and in adult bone marrow of dominant negative Erg transgenic miceNoxp20 and Noxp70, two new markers of early neuronal differentiation, detected in teratocarcinoma-derived neuroectodermic precursor cells.Embryonic stem cells: a promising tool for cell replacement therapy.Parthenogenesis-derived multipotent stem cells adapted for tissue engineering applications.Chondrocyte phenotype and cell survival are regulated by culture conditions and by specific cytokines through the expression of Sox-9 transcription factor.Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells.Overexpression of murine small heat shock protein HSP25 interferes with chondrocyte differentiation and decreases cell adhesion.Differentiated thick ascending limb (TAL) cultured cells derived from SV40 transgenic mice express functional apical NHE2 isoform: effect of nitric oxide.Oxidized low-density lipoprotein acts synergistically with beta-glycerophosphate to induce osteoblast differentiation in primary cultures of vascular smooth muscle cells.
P2860
Q28585895-88B059CB-11E4-409A-8F7F-F4CE348A711EQ33678389-B79AEA19-0311-473B-8D68-A99BACE7D2B0Q34074295-533E5057-0667-4962-BBDB-1443CA370156Q34479060-8E06F279-FEFF-45E8-808E-9FEF476E31F2Q34572462-EC17BF18-6EFA-4B4F-A36A-371FD1E2CFF2Q35985538-2FA10A2B-68A4-4D69-B720-D3735D50EEE3Q37187159-CD9B1F45-B90C-430A-BB20-AFEE73359B15Q40774788-7DA34ACC-1F56-46BC-91A1-11C0658F771AQ40817472-8D270CEE-CD8C-42AD-871D-652639E2C8CDQ43728190-DB4DC0F0-3C85-422E-A93E-D58191CE8C6DQ44498090-953C84BF-3855-48BC-9F1F-3F5541B0C700Q46608634-8BCCC6AD-653E-4AE5-A319-D57738FC93DA
P2860
Controlled conversion of an immortalized mesodermal progenitor cell towards osteogenic, chondrogenic, or adipogenic pathways.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Controlled conversion of an im ...... genic, or adipogenic pathways.
@ast
Controlled conversion of an im ...... genic, or adipogenic pathways.
@en
type
label
Controlled conversion of an im ...... genic, or adipogenic pathways.
@ast
Controlled conversion of an im ...... genic, or adipogenic pathways.
@en
prefLabel
Controlled conversion of an im ...... genic, or adipogenic pathways.
@ast
Controlled conversion of an im ...... genic, or adipogenic pathways.
@en
P2093
P2860
P356
P1476
Controlled conversion of an im ...... genic, or adipogenic pathways.
@en
P2093
P2860
P304
P356
10.1083/JCB.130.6.1461
P407
P577
1995-09-01T00:00:00Z